{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:56:26Z","timestamp":1791640586091,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000150","name":"Canadian Breast Cancer Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000147","name":"Canadian Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["HU"],"award-info":[{"award-number":["HU"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014158","name":"Humanity United","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014158","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.actbio.2019.11.036","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:19:42Z","timestamp":1574338782000},"page":"351-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies"],"prefix":"10.1016","volume":"102","author":[{"given":"Hamidreza Montazeri","family":"Aliabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remant","family":"Bahadur K.C.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emira","family":"Bousoik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryley","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Barbarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Mahdipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-4170","authenticated-orcid":false,"given":"Hasan","family":"Uluda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2019.11.036_bib0001","series-title":"U.S. Cancer Statistics Data Visualizations Tool","year":"2018"},{"key":"10.1016\/j.actbio.2019.11.036_bib0002","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2019.11.036_bib0003","first-page":"439","article-title":"Breast cancer statistics, 2017, racial disparity in mortality by state","volume":"67","author":"DeSantis","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.actbio.2019.11.036_bib0004","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","article-title":"Molecular alterations in triple-negative breast cancer-the road to new treatment strategies","volume":"389","author":"Denkert","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2019.11.036_bib0005","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2019.11.036_bib0006","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)32419-9","article-title":"Advances in the treatment of advanced oestrogen-receptor-positive breast cancer","volume":"389","author":"Turner","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2019.11.036_bib0007","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.ajpath.2013.07.005","article-title":"Targeted therapy for breast cancer","volume":"183","author":"Mohamed","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0008","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/his.13642","article-title":"Breast cancer intratumour heterogeneity: current status and clinical implications","volume":"73","author":"Joseph","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.actbio.2019.11.036_bib0009","unstructured":"Canadian Cancer Society, Survival statistics for breast cancer. 2018, https:\/\/www.cancer.ca\/en\/cancer-information\/cancer-type\/breast\/prognosis-and-survival\/survival-statistics\/?region=on (accessed on Nov 25, 2019)."},{"key":"10.1016\/j.actbio.2019.11.036_bib0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2374","article-title":"Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival","volume":"8","author":"Roderick","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2019.11.036_bib0011","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.suronc.2015.05.004","article-title":"High co-expression of Sp1 and HER-2 is correlated with poor prognosis of gastric cancer patients","volume":"24","author":"Jiang","year":"2015","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0012","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2019.11.036_bib0013","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc3081","article-title":"Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells","volume":"11","author":"Tyson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2019.11.036_bib0014","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3389\/fphar.2018.01285","article-title":"Kinome-wide siRNA screening identifies Src-enhanced resistance of chemotherapeutic drugs in triple-negative breast cancer cells","volume":"9","author":"Tzeng","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/cgt.2013.8","article-title":"Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells","volume":"20","author":"Aliabadi","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.actbio.2019.11.036_bib0016","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2217\/nnm-2016-0178","article-title":"Polymeric micelles for MCL-1 gene silencing in breast tumors following systemic administration","volume":"11","author":"Garg","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.actbio.2019.11.036_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fbioe.2015.00014","article-title":"Targeting cell cycle proteins in breast cancer cells with siRNA by using lipid-substituted polyethylenimines","volume":"3","author":"Parmar","year":"2015","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0018","doi-asserted-by":"crossref","first-page":"31707","DOI":"10.1038\/srep31707","article-title":"Cellular adhesome screen identifies critical modulators of focal adhesion dynamics, cellular traction forces and cell migration behaviour","volume":"6","author":"Fokkelman","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2019.11.036_bib0019","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.biomaterials.2011.11.079","article-title":"Supramolecular assemblies in functional siRNA delivery: where do we stand?","volume":"33","author":"Aliabadi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.11.036_bib0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cbi.2010.12.013","article-title":"Expression of estrogen and progesterone receptors and estrogen metabolizing enzymes in different breast cancer cell lines","volume":"191","author":"Hevir","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.actbio.2019.11.036_bib0021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13058-017-0855-0","article-title":"Molecular characterization of breast cancer cell lines through multiple omic approaches","volume":"19","author":"Smith","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"Suppl 7","key":"10.1016\/j.actbio.2019.11.036_bib0022","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s12864-016-2911-z","article-title":"Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer","volume":"17","author":"Jiang","year":"2016","journal-title":"BMC Genom."},{"key":"10.1016\/j.actbio.2019.11.036_bib0023","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mabi.201000402","article-title":"Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers","volume":"11","author":"Aliabadi","year":"2011","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2019.11.036_bib0024","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fonc.2018.00287","article-title":"\u201cDo we know jack\u201d about JAK? A closer look at JAK\/STAT signaling pathway","volume":"8","author":"Bousoik","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0025","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1073\/pnas.052715299","article-title":"Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2\/HER-2 oncoprotein and c-jun and c-fos oncogenes","volume":"99","author":"Bajo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2019.11.036_bib0026","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1158\/0008-5472.CAN-05-4345","article-title":"Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer","volume":"66","author":"Datta","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2019.11.036_bib0027","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ijc.31067","article-title":"Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line","volume":"142","author":"Korch","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.actbio.2019.11.036_bib0028","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/npjbcancer.2015.2","article-title":"Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014","volume":"1","author":"Prasad","year":"2015","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.actbio.2019.11.036_bib0029","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/mp900074d","article-title":"Aliphatic lipid substitution on 2kDa polyethylenimine improves plasmid delivery and transgene expression","volume":"6","author":"Neamnark","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.11.036_bib0030","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1039\/C4TB02101K","article-title":"Additive nanocomplexes of cationic lipopolymers for improved non-viral gene delivery to mesenchymal stem cells","volume":"3","author":"Bahadur","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2019.11.036_bib0031","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.chembiol.2012.06.014","article-title":"Cellular uptake mechanisms and endosomal trafficking of supercharged proteins","volume":"19","author":"Thompson","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0032","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/cbin.10424","article-title":"The effect of the size of fluorescent dextran on its endocytic pathway","volume":"39","author":"Li","year":"2015","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.actbio.2019.11.036_bib0033","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1021\/mp900023v","article-title":"A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery","volume":"6","author":"Lu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.actbio.2019.11.036_bib0034","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymthe.2005.03.038","article-title":"Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes","volume":"12","author":"Rejman","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.actbio.2019.11.036_bib0035","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1021\/acsomega.7b00741","article-title":"Difatty acyl-conjugated linear and cyclic peptides for siRNA delivery","volume":"2","author":"Do","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.actbio.2019.11.036_bib0036","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s11095-015-1741-z","article-title":"Effect of siRNA pre-Exposure on subsequent response to siRNA therapy","volume":"32","author":"Aliabadi","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2019.11.036_bib0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2013.08.012","article-title":"Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy","volume":"172","author":"Aliabadi","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.actbio.2019.11.036_bib0038","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1016\/j.biomaterials.2012.06.093","article-title":"Cellular uptake pathways of lipid-modified cationic polymers in gene delivery to primary cells","volume":"33","author":"Hsu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2019.11.036_bib0039","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jcis.2017.05.009","article-title":"Disassembly of micelle-like polyethylenimine nanocomplexes for siRNA delivery: high transfection efficiency and reduced toxicity achieved by simple reducible lipid modification","volume":"504","author":"Guo","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.actbio.2019.11.036_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.colsurfb.2013.11.024","article-title":"Selective blocking of primary amines in branched polyethylenimine with biocompatible ligand alleviates cytotoxicity and augments gene delivery efficacy in mammalian cells","volume":"115","author":"Tripathi","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.actbio.2019.11.036_bib0041","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1002\/smll.201501167","article-title":"Peptide-like polymers exerting effective glioma-targeted siRNA delivery and release for therapeutic application","volume":"11","author":"An","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.actbio.2019.11.036_bib0042","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2011.11.006","article-title":"Efficient systemic delivery of siRNA to the mouse liver by pegylated lipopolymer","volume":"427","author":"Liu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2019.11.036_bib0043","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/bc9001536","article-title":"Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery","volume":"20","author":"Philipp","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.actbio.2019.11.036_bib0044","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.nano.2013.07.016","article-title":"Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components","volume":"10","author":"Navarro","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2019.11.036_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1752-0509-5-19","article-title":"Modeling RNA interference in mammalian cells","volume":"5","author":"Cuccato","year":"2011","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.actbio.2019.11.036_bib0046","doi-asserted-by":"crossref","first-page":"10623","DOI":"10.1093\/nar\/gkv1200","article-title":"RNAi revised\u2013target mRNA-dependent enhancement of gene silencing","volume":"43","author":"Dornseifer","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.actbio.2019.11.036_bib0047","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1021\/acs.molpharmaceut.6b00711","article-title":"Single and combinational siRNA therapy of cancer cells: probing changes in targeted and nontargeted mediators after siRNA treatment","volume":"13","author":"Aliabadi","year":"2016","journal-title":"Mol. Pharm."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611930786X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611930786X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:54:04Z","timestamp":1778824444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270611930786X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":47,"alternative-id":["S174270611930786X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2019.11.036","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic comparison of lipopolymers for siRNA delivery to multiple breast cancer cell lines: In vitro studies","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2019.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}